Gene · 4171
Papers3,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomes of the autonomous parvovirus minute virus of mice induce replication stress through RPA exhaustion. | PLoS Pathog | 2023 | 37253065 | PubTator, text mining | PubMed |
| MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma. | J Cell Mol Med | 2023 | 37246638 | PubTator, text mining | PubMed |
| Editorial: Multi-omics data integration: key to thoroughly understanding the immune system. | Front Cell Dev Biol | 2023 | 37228655 | PubTator, text mining | PubMed |
| N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis. | Genes Dis | 2023 | 37223505 | PubTator, text mining | PubMed |
| Identification of natural compound garcinone E as a novel autophagic flux inhibitor with anticancer effect in nasopharyngeal carcinoma cells. | Pharm Biol | 2023 | 37203204 | PubTator, text mining | PubMed |
| De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues. | Hum Genet | 2023 | 37198333 | PubTator, text mining | PubMed |
| Quantitative proteomic studies addressing unmet clinical needs in sarcoma. | Front Oncol | 2023 | 37197427 | PubTator, text mining | PubMed |
| The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response. | Front Oncol | 2023 | 37197417 | PubTator, text mining | PubMed |
| Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications. | Oncogene | 2023 | 37193819 | PubTator, text mining | PubMed |
| SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer. | Cancers (Basel) | 2023 | 37190199 | PubTator, text mining | PubMed |
| Cannabinoid compounds in combination with curcumin and piperine display an anti-tumorigenic effect against colon cancer cells. | Front Pharmacol | 2023 | 37180710 | PubTator, text mining | PubMed |
| Neuropathology of incidental Lewy body & prodromal Parkinson's disease. | Mol Neurodegener | 2023 | 37173733 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| The assembly of the MCM2-7 hetero-hexamer and its significance in DNA replication. | Biochem Soc Trans | 2023 | 37145026 | PubTator, text mining | PubMed |
| Mutational analysis of minichromosome maintenance complex component (MCM) family genes in Chinese Han women with polycystic ovarian syndrome. | Gynecol Endocrinol | 2023 | 37132453 | PubTator, text mining | PubMed |
| Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex. | iScience | 2023 | 37123243 | PubTator, text mining | PubMed |
| Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics. | Int J Mol Sci | 2023 | 37108690 | PubTator, text mining | PubMed |
| Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines. | Int J Mol Sci | 2023 | 37108579 | PubTator, text mining | PubMed |
| Revisiting Genetic Epidemiology with a Refined Targeted Gene Panel for Hereditary Hearing Impairment in the Taiwanese Population. | Genes (Basel) | 2023 | 37107638 | PubTator, text mining | PubMed |
| A Systematic Review of the Heterogenous Gene Expression Patterns Associated with Multidrug Chemoresistance in Conventional Osteosarcoma. | Genes (Basel) | 2023 | 37107591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4171/papers?page=18